Delivery Order SPE2DB22D3301-SPE2DB24FY5EP

Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $14,296.48 delivery order contract is for the supply of 4564002351 Pirfenidone 801 mg tablets to support military treatment programs and facilities. The contract is a firm fixed price arrangement with a performance period ending on March 19, 2024. AmerisourceBergen Drug Corp serves as the...
This federal contract award, valued at $3,433.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PIRFENIDONE 267 MG TABLET 90S, a pharmaceutical product, with a performance period ending on February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,440.79, is for the delivery of 4566594653 - Pirfenidone 801 mg Tablets, 90-count, and does not have a set-aside designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) for the supply of Pirfenidone 801 mg tablets. The $9,653.84 firm fixed price contract has a completion date of March 5, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,370.34 firm fixed-price delivery order is for the supply of 4,566,831,885 units of the drug Pirfenidone 267 mg Tablet in 90-count bottles. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,246.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pirfenidone 801 mg tablets, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Pirfenidone 801 mg tablet in 90-count bottles. The contract has a ceiling value of $5,152.19 and an ultimate completion date of April 17, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the provision of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,275.87, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,285.75 firm fixed-price delivery order is for the supply of 4,564,997,970 units of Pyrazinamide 500 mg tablets. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $22,621.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of pharmaceutical products and medical supplies, with an ultimate completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY5EP
    Delivery Order

This federal contract award, valued at $16,798.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order (DO) for the supply of 4564359612 - Pirfenidone 267 mg tablets, with a firm fixed price and an ultimate completion date of April 23, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This particular contract award was made on a full and open competition basis, with no set-aside designation.

Generated 7/22/24, 9:26 AM